Forebyggelse af Rhesusimmunisering. I. Teoretisk baggrund og imödegåelse af risiko i förste halvdel af graviditeten
Engelsk titel: Prevention of Rh immunisation. I. Theoretical background and management of the risk during the first half of pregnancy
Läs online
Författare:
Falck Larsen J
;
Bock JE
;
Jörgensen JR
Email: falcklarsen@dadlnet.dk
Språk: Dan
Antal referenser: 40
Dokumenttyp:
Översikt
UI-nummer: 04081009
Sammanfattning
Based on evidence from the literature, the following guidelines are recommended: Because of the small amount of fetal erythrocytes, IgG anti-D is not needed after ectopic pregnancy, miscarriage or induced abortion during the first eight weeks of gestation. After eight weeks, 50 µ g of IgG anti-D should be given to all RhD negative non-sensitised women after ectopic pregnancy, miscarriage or induced abortion (regardless of method). 50 µ g of IgG anti-D should be given to all RhD negative non-sensitised women undergoing an invasive procedure (chorion villous sampling, amniocentesis). IgG anti-D is not needed in the case of a complete hydatidiform mole. Women with a partial mole should receive IgG anti-D after the same principles as in the case of spontaneous abortion. IgG anti-D is not needed in cases of threatened abortion except when excessive feto-maternal bleeding is present.